NPR logo

Freud, Jung And What Went Wrong

  • Download
  • <iframe src="https://www.npr.org/player/embed/143063908/143092905" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Freud, Jung And What Went Wrong

Movie Interviews

Freud, Jung And What Went Wrong

Freud, Jung And What Went Wrong

  • Download
  • <iframe src="https://www.npr.org/player/embed/143063908/143092905" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A Woman Of Some Importance: Sabine Spielrein, one of Karl Jung's celebrated patients, later became a psychiatrist herself — and, as screenwriter Christopher Hampton tells NPR's Rachel Martin, an influence on both Jung and Sigmund Freud. Keira Knightley plays Spielrein in the new film A Dangerous Method. /Sony Pictures Classics hide caption

toggle caption /Sony Pictures Classics

A Woman Of Some Importance: Sabine Spielrein, one of Karl Jung's celebrated patients, later became a psychiatrist herself — and, as screenwriter Christopher Hampton tells NPR's Rachel Martin, an influence on both Jung and Sigmund Freud. Keira Knightley plays Spielrein in the new film A Dangerous Method.

/Sony Pictures Classics

Carl Jung and Sigmund Freud are known as the fathers of psychoanalysis, but they focused on different things. Freud's attention was on the sexual underpinnings of — well, almost everything — and Jung was known for his mystical bent and dream theories.

For years, the two were close friends and collaborators but they had a falling out that ultimately ended their relationship. Turns out, there was a woman involved. Her name was Sabina Spielren.

The stories of all three are woven together in a new film, A Dangerous Method.

Screenwriter Christopher Hampton tells weekends on All Things Considered guest host Rachel Martin that Spielrein, a young girl from Russia, first met Carl Jung in Zurich on the eve of World War I.

We no longer support commenting on NPR.org stories, but you can find us every day on Facebook, Twitter, email, and many other platforms. Learn more or contact us.